or
forgot password

    • cancer clinical trials in metairie, LA

    • A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

    Metairie, Louisiana 70006
    Biochemical-recurrent Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
    A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
    Jayne Gurtler MD, Laura Brinz MD, Angelo Russo MD and Janet Burroff MD APMC
    Metairie, Louisiana
    Solid Tumors
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    East Jefferson General Hospital
    Metairie, Louisiana 70011
    Brain and Central Nervous System Tumors
    Talc in Treating Patients With Malignant Pleural Effusion
    East Jefferson General Hospital
    Metairie, Louisiana 70011
    Metastatic Cancer
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    East Jefferson General Hospital
    Metairie, Louisiana 70011
    Breast Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    East Jefferson General Hospital
    Metairie, Louisiana 70011
    Prostate Cancer
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    East Jefferson General Hospital
    Metairie, Louisiana 70011
    Pancreatic Cancer
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    J Gurtler, Hematology and Oncology
    Metairie, Louisiana 70006
    Pancreatic Cancer
    Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

    Metairie, Louisiana 70006
    Carcinoma, Non-Small-Cell Lung
    Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
    Hematology and Oncology Services
    Metairie, Louisiana 70006
    Non-Hodgkin's Lymphoma, Lymphoma, B-cell, Lymphoma, Low-grade
    Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

    Metairie, Louisiana 70006
    Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastases, Neoplasm
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Oncology and Hematology
    Metairie, Louisiana 70006-2921
    Non-Hodgkin's Lymphoma
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Hematology and Oncology Specialists, LLC - Metairie
    Metairie, Louisiana 70006
    Kidney Cancer
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana 70006
    Non Small Cell Lung Cancer
    A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

    Metairie, Louisiana 70006
    Breast Neoplasms
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Hematology & Oncology Specialists LLC
    Metairie, Louisiana 70115
    Myelodysplastic Syndromes
    A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

    Metairie, Louisiana 70006
    Carcinoma, Hepatocellular
    Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
    Jayne S. Gurtler, MD, Laura A. Brinz, MD & Angelo Russo, MD
    Metairie, Louisiana 70006
    Leukemia, Myeloid, Chronic Phase
    Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Metairie, Louisiana 70006
    Acute Myeloid Leukemia
    A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer
    Cancer and Blood Institute
    Metairie, Louisiana 70006
    Non-Small Cell Lung Cancer
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana 70006
    Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1906
    Metairie, Louisiana 70006
    Crohn's Disease
    Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

    Metairie, Louisiana 70006
    Leukemia, Lymphocytic, Chronic, B-Cell
    Trial of Decitabine in Patients With Acute Myeloid Leukemia

    Metairie, Louisiana 70006
    Acute Myeloid Leukemia
    Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
    East Jefferson OB/GYN
    Metairie, Louisiana 70006
    Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia
    Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy
    Jayne Gurtler, M.D.
    Metairie, Louisiana 70006
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana 70006
    Non-Small Cell Lung Cancer
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Oncology and Hematology
    Metairie, Louisiana 70006-2921
    Gastric Cancer
    A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
    Hematology & Oncology Specialists, LLC
    Metairie, Louisiana 70006
    Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
    A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana 70006
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumor
    An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Metairie, Louisiana 70006
    Lung Neoplasms
    Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects

    Metairie, Louisiana 70006
    Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell Refractory
    Endometrial Safety Study

    Metairie, Louisiana 70006
    Postmenopause